scispace - formally typeset
Open AccessJournal ArticleDOI

Sitting on the FENSA: WHO engagement with industry.

Reads0
Chats0
TLDR
When decisions are made that will impact on people’s health, who should be represented at the policy-making table?
About
This article is published in The Lancet.The article was published on 2016-07-30 and is currently open access. It has received 28 citations till now. The article focuses on the topics: Sitting.

read more

Citations
More filters
Journal ArticleDOI

Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure

TL;DR: Reforms are identified that will be needed to the global health architecture to govern NCD risks, including to strengthen its ability to consolidate the collective power of diverse stakeholders, its authority to develop and enforce clear measures to address risks, as well as establish monitoring and rights-based accountability systems across all actors to drive measurable, equitable and sustainable progress.
Journal ArticleDOI

Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool

TL;DR: Responses to the WHO tool reflected contrasting conceptualisations of COI and implications for health governance, illustrating how contrasting positions on COI are central to understanding broader debates in nutrition policy and across global health governance.
Journal ArticleDOI

Gender blind? An analysis of global public-private partnerships for health

TL;DR: GPPPH need to become serious in how they “do” gender; it needs to be mainstreamed through the regular activities, deliverables and systems of accountability, and the entire global health community needs to pay greater attention to tackling the major burden of NCDs, including addressing the gendered nature of risk.
Journal ArticleDOI

Unpacking policy formulation and industry influence: the case of the draft control of marketing of alcoholic beverages bill in South Africa

TL;DR: It is shown that achieving policy coherence across government departments poses a major challenge to achieving effective health policy formulation and that networks of actors with commercial and financial interests use diverse strategies to influence policy formulation processes to avoid regulation.
References
More filters
Journal ArticleDOI

Priority actions for the non-communicable disease crisis

TL;DR: The Lancet NCD Action Group and the NCD Alliance propose five overarching priority actions for the response to the crisis and the delivery of five priority interventions--tobacco control, salt reduction, improved diets and physical activity, reduction in hazardous alcohol intake, and essential drugs and technologies.
Journal ArticleDOI

Big Food, Food Systems, and Global Health

TL;DR: Guest editors David Stuckler and Marion Nestle lay out why more examination of the food industry is necessary, and offer three competing views on how public health professionals might engage with Big Food.
Posted Content

Democracy in Global Governance: The Promises and Pitfalls of Transnational Actors

TL;DR: In this paper, the authors assess the promises and pitfalls of transnational actors' role in global governance and explore how the structuring and operation of international institutions, public-private partnerships, and transnational agents themselves may facilitate expanded participation and enhanced accountability.
Journal ArticleDOI

Democracy in Global Governance: The Promises and Pitfalls of Transnational Actors

TL;DR: In this article, the authors assess the promises and pitfalls of transnational actors' participation in global policymaking and assess the conditions for democracy in global governance through a combination of normative political theory and positive empirical research, finding considerable support for an optimistic verdict on the democratizing potential of trans-national actor involvement, but also identifying hurdles in democratic theory and the practice of global governance that motivate a more cautious outlook.
Journal ArticleDOI

Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed?

TL;DR: Five large private global health foundations are examined and the scope of relationships between these tax-exempt foundations and for-profit corporations including major food and pharmaceutical companies are reported on.
Related Papers (2)
Frequently Asked Questions (8)
Q1. What contributions have the authors mentioned in the paper "Sitting on the fensa: who engagement with industry" ?

In this paper, the World Health Assembly ( WHA ) reached consensus: `` WHO engages with non-State actors to encourage them to protect and promote public health '' and considered non-state actors as `` nongovernmental organizations [ NGOs ], private sector entities, philanthropic foundations and academic institutions ''. 

WHO and its governing body have taken an important step in democratizing the invite list to the policy table and establishing the dining etiquette. 

Do the authors rely upon self-regulation by industry (e.g., marketing codes or voluntary initiatives to reduce harmful exposure), co-regulation of the activities of industry (e.g. public sector partnerships with the private sector are an overarching approach within of WHO’s 2013-2020 Global Action Plan on NCDs8), or public regulation of private sector activities. 

A small but not insignificant part of the project entails embracing the public interest NGOs, which it has too long treated as adversaries, as the partners it needs to generate both public support and political incentives to induce national leaders to act. 

Concerns have long been raised about potential and actual conflicts of interest arising from WHO’s engagement with non-State actors (NSA), particularly those whose mandate hingesforemost upon the pursuit of profit rather than public health. 

Members States were generally supportive of the Framework, but NGOs voiced concern that “FENSA will increase….problematic entanglements between WHO and powerful private sector actors”, and were disappointed that the Framework fails to “acknowledge the different nature – and thus different roles – public and private sector actors should play in global health governance”3. 

Now WHO needs to jump decisively off the right side of the fence and take more impactful measures, globally and nationally, to protect the health of the public by aggressively supporting governments and their partners to govern the health impact of Big Industry. 

A Reuters investigation, for example, found not only that regional office PAHO had accepted money from companies such as Coca-Cola, Nestle and Unilever, but also that at least two of the 15 members of WHO’s Nutrition Guidance Expert Advisory Group had direct financial ties to the food industry5.